Save your place

Sign in to WhoBought

Please try again later.

TScan Therapeutics, Inc. (TCRX) institutional ownership

Latest close $0.79 Jul 24, 2026
Market cap$92M 52-week range SectorHealthcare
Funds holding · Q1 2026
54
reported TCRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
23 buyers · 31 sellers

TScan Therapeutics, Inc. (TCRX) price and institutional activity

Dates

Q1 2026

$0 bought by 23 investors
Millennium Management LLCJacobs Levy Equity Management, Inc +21 more
$0 sold by 31 investors
Aberdeen Group PLCTwo Sigma Advisers, LP +29 more
Bought Sold Totals per quarter; hover a bar for the names.

TScan Therapeutics, Inc. (TCRX) institutional activity · 54

Investor Type Est. change Change Δ Own Date
Millennium Management LLC · Added
Change +1.1M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +1.1M Q1 2026
Aberdeen Group PLC · Reduced
Change −867K Date Q1 2026
Aberdeen Group PLC Reduced· Q1 2026 −867K Q1 2026
Jacobs Levy Equity Management, Inc · Added
Change +620K Date Q1 2026
Jacobs Levy Equity Management, Inc Added· Q1 2026 +620K Q1 2026
Two Sigma Investments, LP · Added
Change +558K Δ Own +85.7% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +558K +85.7% Q1 2026
Two Sigma Advisers, LP · Exited
Change −354K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −354K −100.0% Q1 2026
Bvf Inc · Added
Change +338K Date Q1 2026
Bvf Inc Added· Q1 2026 +338K Q1 2026
D. E. Shaw & Co., Inc. · Added
Change +250K Δ Own +360.3% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +250K +360.3% Q1 2026
Jane Street Group, LLC · Reduced
Change −244K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −244K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +224K +19.6% Q1 2026
Acadian Asset Management LLC · Added
Change +172K Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +172K Q1 2026
Xtx Topco Ltd · Reduced
Change −158K Date Q1 2026
Xtx Topco Ltd Reduced· Q1 2026 −158K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +156K +95.5% Q1 2026
Gsa Capital Partners LLP · Added
Change +153K Date Q1 2026
Gsa Capital Partners LLP Added· Q1 2026 +153K Q1 2026
Verdad Advisers, LP · New
Change +134K Date Q1 2026
Verdad Advisers, LP New· Q1 2026 +134K Q1 2026
Marshall Wace, LLP · Reduced
Change −102K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −102K Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 54

Famous investor activity in TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics, Inc. (TCRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Baker Bros. Advisors LP · Director 2 operations 134K
Owned 67K Trade date May 20, 2026 Filed date May 22, 2026
Baker Bros. Advisors LP Director 2 operations 134K 67K May 20, 2026 May 22, 2026
Woods Keith · Director Grant (A) 67K
Owned 67K Trade date May 20, 2026 Filed date May 22, 2026
Woods Keith Director Grant (A) 67K 67K May 20, 2026 May 22, 2026
Nicholson Garry A. · Director Grant (A) 67K
Owned 67K Trade date May 20, 2026 Filed date May 22, 2026
Nicholson Garry A. Director Grant (A) 67K 67K May 20, 2026 May 22, 2026
Gruia Gabriela · Director Grant (A) 67K
Owned 67K Trade date May 20, 2026 Filed date May 22, 2026
Gruia Gabriela Director Grant (A) 67K 67K May 20, 2026 May 22, 2026
Dorton Katina · Director Grant (A) 67K
Owned 67K Trade date May 20, 2026 Filed date May 22, 2026
Dorton Katina Director Grant (A) 67K 67K May 20, 2026 May 22, 2026
Klencke Barbara · Director Grant (A) 67K
Owned 67K Trade date May 20, 2026 Filed date May 22, 2026
Klencke Barbara Director Grant (A) 67K 67K May 20, 2026 May 22, 2026
Amello Jason · Officer Grant (A) 350K
Owned 350K Trade date Jan 20, 2026 Filed date Jan 22, 2026
Amello Jason Officer Grant (A) 350K 350K Jan 20, 2026 Jan 22, 2026
Macbeath Gavin · Director, Officer Grant (A) 1.2M
Owned 1.2M Trade date Jan 20, 2026 Filed date Jan 22, 2026
Macbeath Gavin Director, Officer Grant (A) 1.2M 1.2M Jan 20, 2026 Jan 22, 2026
Dworak Leiden · Officer Grant (A) 100K
Owned 100K Trade date Jan 20, 2026 Filed date Jan 22, 2026
Dworak Leiden Officer Grant (A) 100K 100K Jan 20, 2026 Jan 22, 2026
Louis Chrystal · Officer Grant (A) 420K
Owned 420K Trade date Jan 20, 2026 Filed date Jan 22, 2026
Louis Chrystal Officer Grant (A) 420K 420K Jan 20, 2026 Jan 22, 2026
Zdraveski Zoran · Officer Grant (A) 350K
Owned 350K Trade date Jan 20, 2026 Filed date Jan 22, 2026
Zdraveski Zoran Officer Grant (A) 350K 350K Jan 20, 2026 Jan 22, 2026
Lynx1 Capital Management LP · 10% Owner Buy +$6K
Price $0.90 Qty +6K Owned 8.0M Trade date Dec 23, 2025 Filed date Dec 23, 2025
Lynx1 Capital Management LP 10% Owner Buy $0.90 +6K +$6K 8.0M Dec 23, 2025 Dec 23, 2025
Lynx1 Capital Management LP · 10% Owner Buy +$68K
Price $0.90 Qty +76K Owned 8.0M Trade date Dec 22, 2025 Filed date Dec 23, 2025
Lynx1 Capital Management LP 10% Owner Buy $0.90 +76K +$68K 8.0M Dec 22, 2025 Dec 23, 2025
Lynx1 Capital Management LP · 10% Owner Buy +$72K
Price $0.90 Qty +80K Owned 7.9M Trade date Dec 19, 2025 Filed date Dec 23, 2025
Lynx1 Capital Management LP 10% Owner Buy $0.90 +80K +$72K 7.9M Dec 19, 2025 Dec 23, 2025
14 of 14

TScan Therapeutics, Inc. (TCRX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Lynx1 Capital Management LP 7.9M
% of shares outstanding 15.0% Filing date Aug 14, 2025
Lynx1 Capital Management LP 7.9M 15.0% Aug 14, 2025
Blackrock, Inc. 4.6M
% of shares outstanding 9.5% Filing date Nov 8, 2024
Blackrock, Inc. 4.6M 9.5% Nov 8, 2024
Adage Capital Management, L.P. 3.5M
% of shares outstanding 7.1% Filing date Feb 12, 2025
Adage Capital Management, L.P. 3.5M 7.1% Feb 12, 2025
K2 Healthventures Equity Trust LLC 3.6M
% of shares outstanding 6.9% Filing date Feb 14, 2025
K2 Healthventures Equity Trust LLC 3.6M 6.9% Feb 14, 2025
Baker Bros. Advisors LP 2.8M
% of shares outstanding 6.1% Filing date Apr 23, 2024
Baker Bros. Advisors LP 2.8M 6.1% Apr 23, 2024
Biotechnology Value Fund L P 3.0M
% of shares outstanding 5.4% Filing date May 15, 2026
Biotechnology Value Fund L P 3.0M 5.4% May 15, 2026
BlackRock Inc. 1.3M
% of shares outstanding 3.0% Filing date Jun 8, 2023
BlackRock Inc. 1.3M 3.0% Jun 8, 2023
Adage Capital Management, L.P. 1.4M
% of shares outstanding 2.5% Filing date Aug 12, 2025
Adage Capital Management, L.P. 1.4M 2.5% Aug 12, 2025
8 of 10

TScan Therapeutics, Inc. (TCRX) ownership FAQ

Who owns TCRX?

54 reporting institutions disclosed TCRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.